Is NHKFF stock a buy after the oversold move?

NHKFF stock can be a tactical buy for short-term traders if volume confirms a breakout. Fundamentals are weak, so use tight stops and small position sizes.

What price targets should investors watch for NHKFF stock?

Watch an initial short-term target at **$0.65**, the 1-year model target at **$0.84**, and a 3-year forecast near **$1.43**. These are model-based and not guarantees.

How does Meyka AI grade NHKFF stock?

Meyka AI rates NHKFF with a score out of 100: **56.74** (Grade **C+**) with a suggestion to **HOLD**. This factors in benchmark and sector comparisons and key metrics.

What are the main risks for NHKFF stock?

Key risks include negative earnings (EPS **-2,327.10**), weak margins, high leverage (debt-to-equity **12.14**), low liquidity, and execution risk for any recovery plan.

US Stocks

NHKFF Nichi-Iko Pharmaceutical (PNK) $0.359 21 Jan 2026: Oversold bounce setup

ByHuzaifa Zahoor January 22, 2026

NHKFF stock is trading at $0.359 on 21 Jan 2026 in regular market hours on the PNK exchange in the United States, showing a spike in activity with 5,000 shares traded versus an average of 1,851. This price sits at the intraday high of $0.359 and matches the 50- and 200-day averages, creating a clean technical reference for an oversold bounce strategy. The company, Nichi-Iko Pharmaceutical Co., Ltd., operates in Healthcare and the drug manufacturers sector. We use Meyka AI-powered market analysis platform signals and price models to frame short-term trade levels and a multi-year outlook for NHKFF stock.